ER+ Breast Cancer Data: SERDs, Pregnancy, and New Targets ER+ Breast Cancer Data: SERDs, Pregnancy, and New Targets

Kathy D. Miller, MD, and Kevin Kalinsky, MD, discuss recent studies important for treating patients with ER-positive disease.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news